We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Longitudinal Survey Analysis in Lymphoma Survivors (CLEAR Stress)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01469754
Recruitment Status : Completed
First Posted : November 10, 2011
Last Update Posted : May 5, 2014
Information provided by (Responsible Party):

Study Description
Brief Summary:

Posttraumatic Stress Disorder (PTSD) is a well-documented phenomenon that occurs in cancer survivors. PTSD is known to cause problems with anxiety, depression, and quality of life. Furthermore, there is little treatment available for cancer survivors who suffer from PTSD.

Posttraumatic Growth, however, is a lesser known phenomenon that also occurs in cancer survivors. It is a positive psychological phenomenon that occurs in some people who have suffered a traumatic event--the people who are able to note a "greater appreciation for life", a "stronger relationship with their family/friends," or a "new found level of spirituality" are examples of instances of posttraumatic growth.

Coping with Lymphoma to Enhance Adjustment and Reduce Stress in Survivors (CLEAR Stress) is a study designed to compare the development of PTSD versus the development of Posttraumatic Growth in lymphoma patients at any stage of the cancer experience, regardless of treatment. The hypothesis is that posttraumatic growth, if it is significant, can reduce the impact of PTSD symptoms in the survivor.

Condition or disease
Lymphoma Posttraumatic Stress Disorder Posttraumatic Growth Coping Resilience

Study Design

Study Type : Observational
Actual Enrollment : 97 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Coping With Lymphoma to Enhance Adjustment and Reduce Stress in Lymphoma Survivors
Study Start Date : September 2011
Primary Completion Date : July 2013
Study Completion Date : September 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lymphoma
U.S. FDA Resources

Groups and Cohorts

Lymphoma Survivors

Outcome Measures

Primary Outcome Measures :
  1. Posttraumatic Growth [ Time Frame: Measured at enrollment ]

Secondary Outcome Measures :
  1. Posttraumatic Stress Disorder (PTSD) [ Time Frame: Measured at Enrollment ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Lymphoma survivors who have completed initial treatment within the last 3 months

Inclusion Criteria:

  • Diagnosis of Lymphoma (includes Waldenstrom's Macroglobulinemia)
  • Can read/write/understand English without a translator

Exclusion Criteria:

  • Currently Hospitalized
  • Active Psychosis
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01469754

United States, New York
New York Presbyterian/Weill Cornell Center for Lymphoma and Myeloma
New York, New York, United States, 10065
Sponsors and Collaborators
Weill Medical College of Cornell University
Principal Investigator: Regina A Jacob, MD WCMC Research Fellow
More Information

Additional Information:
Responsible Party: Weill Medical College of Cornell University
ClinicalTrials.gov Identifier: NCT01469754     History of Changes
Other Study ID Numbers: 1107011786
First Posted: November 10, 2011    Key Record Dates
Last Update Posted: May 5, 2014
Last Verified: May 2014

Keywords provided by Weill Medical College of Cornell University:
posttraumatic growth
posttraumatic stress

Additional relevant MeSH terms:
Stress Disorders, Post-Traumatic
Neoplasms by Histologic Type
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases
Stress Disorders, Traumatic
Trauma and Stressor Related Disorders
Mental Disorders